drugset / Trial / NCT00808626
Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis
NaSingle-groupOpen-labelDiagnostic
Summary
99mTc-rBitistatin is a radiolabeled polypeptide which is designed to stick to blood clots so that the blood clots can be detected by imaging. The purpose of this trial is to evaluate in patients the safety of 99mTc-rBitistatin and its ability to locate blood clots in the arms and legs.
Timeline
- Start
- 2008-12
- Primary completion
- 2017-03
- Completion
- 2017-03
Outcome
Outcome not reported
Stopped (Business): “Lack of funding to complete trial. A lead member of research team retired.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 99mTc-rBitistatin | Unknown | 0.1 ug/kg | Intravenous |
| Subject | 99mTc-rBitistatin | Unknown | 370 mbq | Intravenous |